Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 268 publications

An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system.

Condition: Richeter's Syndrome (RS)
Journal: Journal of clinical and experimental hematopathology : JCEH
Treatment Used: Ibrutinib
Number of Patients: 1
Published: November 27, 2022

Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia.

Condition: Chronic Lymphocytic Leukemia
Journal: Cells
Treatment Used: Proteasome and mTORC1 Inhibitors
Number of Patients: 0
Published: November 26, 2022

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.

Condition: Previously Treated B-Cell Malignancies
Journal: The Lancet. Haematology
Treatment Used: Zanubrutinib
Number of Patients: 67
Published: November 18, 2022

Research Progress of Oral BCL-2 Inhibitor Venetoclax in the Treatment of Non-Hodgkin's Lymphoma --Review.

Condition: Non-Hodgkin's Lymphoma (NHL)
Journal: Zhongguo shi yan xue ye xue za zhi
Treatment Used: Venetoclax
Number of Patients: 0
Published: October 08, 2022

CLL-246 Venetoclax-Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia: 5-Year Results of the Randomized CLL14 Study.

Condition: Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Venetoclax-Obinutuzumab (Ven-Obi)
Number of Patients: 432
Published: September 27, 2022

CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study.

Condition: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pirtobrutinib
Number of Patients: 323
Published: September 27, 2022

CLL-418 Characteristics and Clinical Outcomes of Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Long-Term Ibrutinib Treatment in the RESONATE-2 Study.

Condition: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Ibrutinib
Number of Patients: 136
Published: September 27, 2022

CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

Condition: Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Zanubrutinib
Number of Patients: 415
Published: September 27, 2022

CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL).

Condition: Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Zanubrutinib vs. Bendamustine Plus Rituximab (BR)
Number of Patients: 479
Published: September 27, 2022

CLL-217 Patient Characteristics and Time to Next Treatment With Ibrutinib and Anti-CD20 Monotherapy as First-Line Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Condition: Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Ibrutinib
Number of Patients: 3226
Published: September 27, 2022

CLL-345 Retrospective Analysis of Real-World Outcomes of Chronic/Small Lymphocytic Leukemia (CLL/SLL) Patients Treated With First-Line Ibrutinib Versus Chemoimmunotherapy (CIT).

Condition: Chronic/Small Lymphocytic Leukemia (CLL/SLL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Ibrutinib
Published: September 27, 2022

Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study.

Condition: Chronic Lymphocytic Leukemia (CLL)
Journal: Leukemia research
Treatment Used: Ofatumumab and Alemtuzumab
Number of Patients: 52
Published: September 17, 2022
Showing 1-12 of 268

Last Updated: 02/19/2023